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Abstract
Previous studies have demonstrated that the use of integrated information from multi-modalities
could significantly improve diagnosis of Alzheimer’s Disease (AD). However, feature selection,
which is one of the most important steps in classification, is typically performed separately for
each modality, which ignores the potential strong inter-modality relationship within each subject.
Recent emergence of multi-task learning approach makes the joint feature selection from different
modalities possible. However, joint feature selection may unfortunately overlook different yet
complementary information conveyed by different modalities. We propose a novel multi-task
feature selection method to preserve the complementary inter-modality information. Specifically,
we treat feature selection from each modality as a separate task and further impose a constraint for
preserving the inter-modality relationship, besides separately enforcing the sparseness of the
selected features from each modality. After feature selection, a multi-kernel Support Vector
Machine (SVM) is further used to integrate the selected features from each modality for
classification. Our method is evaluated using the baseline PET and MRI images of subjects
obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. Our method
achieves a good performance, with an accuracy of 94.37% and an Area Under the ROC Curve
(AUC) of 0.9724 for AD identification, and also an accuracy of 78.80% and an AUC of 0.8284 for
Mild Cognitive Impairment (MCI) identification. Moreover, the proposed method achieves an
accuracy of 67.83% and an AUC of 0.6957 for separating between MCI converters and MCI non-
converters (to AD). These performances demonstrate the superiority of the proposed method over
the state-of-the-art classification methods.
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1. Introduction
Alzheimer’s Disease (AD) is a genetically complex and irreversible neurodegenerative
disorder which is clinically characterized by progressive dementia and neuropsychiatric
symptoms (Blennow et al., 2006). The number of subjects with AD has been predicted to
quadruple by 2050 (Brookmeyer et al., 2007). Although numerous efforts have been made in
the past decades to develop new treatment strategies, there is no effective treatment or
effective diagnostic instrument until now. This causes substantial financial burden to the
society, as well as psychological and emotional burden to patients and their families. Mild
Cognitive Impairment (MCI), an intermediate stage between normal cognition and
dementia, has a high risk of progressing to AD (Petersen et al., 1999). While the annual
incidence rate of healthy subjects to develop AD is 1% to 2% (Bischkopf et al., 2002), the
conversion rate from MCI to AD is reported to be approximately 10% to 15% per year
(Grundman et al., 2004). Thus, it is of great interest to identify MCI and also predict its risk
of progressing to AD.
Accumulating evidence demonstrates that individuals with AD have both functional and
structural changes in the brain, such as loss of grey matter volume (Karas et al., 2003) and
metabolic abnormalities (Matsuda, 2001). However, these findings are mainly obtained
based on group-level statistical comparison, and thus are of limited value for individual-
based disease diagnosis. To overcome this limitation, pattern classification methods have
been used in recent years, and have shown great potential in neuroimaging studies (Fan et
al., 2007; Wee et al., 2013). Unlike group-based comparison approaches, pattern
classification methods are able to detect the fine-grained spatial discriminative patterns,
which are critical for individual-based disease diagnosis. Moreover, some studies have
shown that the combination of complementary information from different imaging
modalities can improve the accuracy in diagnosis of AD and MCI. For example, Dai et al.
(2012b) used both structural Magnetic Resonance Imaging (MRI) and resting-state
functional MRI to classify 16 AD patients from 22 healthy subjects, and achieved a
classification accuracy of 89.47%, which is an increase of 2.63% from the single-modality
based method. Wee et al. (Wee et al., 2012) used both Diffusion Tensor Imaging (DTI) and
resting-state functional MRI to identify 10 individuals with MCI from 17 matched Normal
Controls (NC), and obtained a very promising classification accuracy of 96.3%, which is an
increase of 7.4% from the single-modality based method. Although high classification
accuracies were achieved, the small sample and large feature size problem in these studies
may still lead to data overfitting. Since the original feature space of neuroimaging data is
relatively high compared to the sample size, feature selection is one of the most important
steps in neuroimaging classification. However, in the literature, feature selection in
multimodal classification studies is often performed separately for each imaging modality
without considering the potential strong relationship among different modalities, thus
possibly affecting the final classification results. Hence, it is reasonable to consider
preserving the inter-modality relationship during the feature selection for final improvement
of classification.
Recently, multi-task learning approach has attracted the increasing attention in machine
learning, computer vision, and artificial intelligence (Evgeniou and Pontil, 2007; Zhou et al.,
2011). The main goal of this approach is to capture the intrinsic relationship among different
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tasks with the assumption that these tasks are related to each other. Learning multiple related
tasks simultaneously has been shown to often perform better than learning each task
separately (Evgeniou and Pontil, 2007). Specially, recent emergence of multi-task learning
method enables joint feature selection via group sparsity (i.e. using L2,1 norm) (Liu et al.,
2009). However, this constraint may be too strong, since it forces common features to be
selected for different tasks, without considering that different tasks may need different
features.
In this paper, a novel multi-task learning based feature selection method is proposed to
better preserve the complementary information conveyed by different modalities. More
specifically, selection of features from different modalities is treated as different tasks. To
better capture the complementary information among different modalities, it is also
important to preserve the relationship between the feature vectors derived from different
modalities, especially after their projection onto the lower dimensional feature space. To this
end, a new constraint is imposed to preserve the inter-modality relationship, besides
enforcing the sparseness of the selected features from each modality as popularly used in the
literature. A multi-kernel Support Vector Machine (SVM) is finally used to combine the
selected features from each modality for predicting the classification labels.
The remainder of this paper is organized as follows. Materials and Methods section
furnishes information on the image dataset, preprocessing pipeline, and details of the
proposed framework. Experimental results of the proposed method and some state-of-the-art
methods on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset are
summarized in the Experiment and Results section. The findings of proposed framework are
extensively discussed in the Discussion section, which is followed by the Conclusion
section.
2. Materials and Methods
2.1. Subjects
The data were taken from the ADNI dataset (www.adni.loni.ucla.edu/ADNI). The ADNI
was launched in 2003 by the National Institute on Aging (NIA), the National Institute of
Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration
(FDA), private pharmaceutical companies, and nonprofit organizations, as a $60 million, 5-
year public–private partnership. The primary goal of ADNI has been to test whether serial
MRI, PET, other biological markers, and clinical and neuropsychological assessment can be
combined to measure the progression of MCI and early AD. Determination of sensitive and
specific markers of very early AD progression is intended to aid researchers and clinicians
to develop new treatments and monitor their effectiveness, as well as lessen the time and
cost of clinical trials. The Principal Investigator of this initiative is Dr. Michael W. Weiner,
MD, VA Medical Center and University of California, San Francisco. ADNI is the result of
efforts of many coinvestigators from a broad range of academic institutions and private
corporations, and subjects have been recruited from over 50 sites across the U.S. and
Canada. The initial goal of ADNI was to recruit 800 adults, ages 55 to 90, to participate in
the research, approximately 200 cognitively normal older individuals to be followed for 3
years, 400 people with MCI to be followed for 3 years, and 200 people with early AD to be
followed for 2 years.
All the patients met the following inclusion criteria: 1) diagnosis of AD was made if the
subject had a Mini-Mental State Examination (MMSE) score 20–26, a Clinical Dementia
Rating (CDR) of 0.5 or 1.0, and meets the National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders
Association (NINCDS/ADRDA) criteria for probable AD. 2) Individuals were categorized
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as amnestic MCI if they had an MMSE score 24–30, a CDR of 0.5, a memory complaint,
objective memory loss measured by education adjusted scores on Wechsler Memory Scale
Logical Memory II, absence of significant levels of impairment in other cognitive domains,
while essentially preserved activities of daily living, and an absence of dementia. All NC
individuals met the following criteria: an MMSE score 24–30, a CDR of 0, nondepressed,
non-MCI, and nondemented. The research protocol was approved by each local institutional
review board, and written informed consent was obtained from each subject at the time of
enrollment for imaging and genetic sample collection.
Two hundreds and two subjects from ADNI dataset: 51 patients with AD, 99 patients with
MCI (43 MCI converters who had converted to AD within 18 months and 56 MCI non-
converters who had not converted to AD within 18 months), and 52 NC are analyzed in this
study. Table 1 presents a summary of the demographic characteristics of the used subjects.
2.2. Data acquisition and preprocessing
All structural MRI scans used were acquired using 1.5T scanners. MRI acquisitions were
performed according to the ADNI acquisition protocol (Jack et al., 2008). For the image
preprocessing, we first performed Anterior Commissure - Posterior Commissure (AC-PC)
correction on all images, and then used N3 algorithm (Sled et al., 1998) to correct intensity
inhomogeneity. Skull-stripping (Wang et al., 2011) was then performed, followed by the
registration-based cerebellum removal. We used FAST in FSL (Zhang et al., 2001) to
segment brain into three different tissue types: Grey Matter (GM), White Matter (WM) and
Cerebrospinal Fluid (CSF). We registered the template into subject specific space using
HAMMER (Shen and Davatzikos, 2002) to preserve the absolute image volume of each
subjects. Subsequently, we parcellated the brain in 93 regions-of-interest, based on the Jacob
template (Kabani, 1998). GM volume of each ROI was extracted as the feature for the MRI
modality. PET images were acquired 30–60 min post-injection, averaged, spatially aligned,
interpolated to a standard voxel size, intensity normalized, and smoothed to a common
resolution of 8-mm full width at half maximum. For each subject, we aligned the
preprocessed PET image to its respective MRI image using affine registration. Then we
calculated the average intensity of each regions-of-interest and treated it as the feature for
the PET modality. Thus, we finally have 93 features from the MRI image and 93 features
from the PET image, for each subject.
2.3. Overview of our method
An overview of the proposed classification pipeline was illustrated in Fig. 1. From the
preprocessed PET and MRI images, we first extracted the respective regional features as
motioned above. Based on these features, inter-modality relationship constrained multi-task
feature selection was applied to select the important features from each modality. Based on
the selected features, a kernel matrix was constructed for each modality. Then, a fused
kernel matrix was further constructed, based on the individual matrix from each modality,
for classification by using SVM.
Although we used regional features, the number of features was relatively large compared to
the sample size, and most importantly, some of them were irrelevant or redundant for
classification. Thus, an effective feature selection could not only speed up computation, but
also improve the classification performance. Unlike the traditional single-task feature
selection approaches which treat each task independently, such as Least Absolute Shrinkage
and Selection Operator (LASSO) (Tibshirani, 1996), multi-task feature selection approaches
can often significantly improve the classification performance by learning multiple tasks
simultaneously (Evgeniou and Pontil, 2007).
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2.4. Multi-task feature selection
Let  be a n × d matrix that represents d features of n training
samples for modality j, j = 1, …, m, where m is the total number of modalities. Let
 be a n dimensional corresponding target vector (with
classification labels as values of +1 or −1 in this study) for modality j. Linear regression
model used for prediction can be defined as follows (Zhou et al., 2011):
(1)
where wj ∈ Rd×1 and ŷj denote, respectively, the regression coefficient vector and the
predicted label vector of the j-th modality. To estimate all m regression coefficient vectors
from all m modalities such as W = [w1, …, wj, …, wm], one of the popular approaches is to
minimize the following objective function:
(2)
where λ1 > 0 is a regularization parameter which controls the sparsity of the model, with a
higher value leading to a sparser model, i.e., more elements in W are zero. ||W||1 is the L1
norm of W, which is defined as . This regression approach is
known as LASSO.
The limitation of above-mentioned model is that each task is treated independently.
Although we can use the recent emergence of multi-task feature learning method, under
framework of group sparsity (i.e., L2,1 norm (Liu et al., 2009)), to guide selection of
common features from different modalities, the complementary information conveyed by
different modalities might be discarded after this too strong group sparsity constraint and
thus affect the final classification results.
To address this problem, we propose to preserve the relative distance between the feature
vectors extracted from different modalities of the same subject (also called as inter-modality
relationship), before and after feature projection, by imposing the following constraint:
(3)
where  and  denote the feature vectors of the j-th and k-th modalities in the i-th subject,
respectively.  is the relative distance between the feature vectors  and  before
feature projection, while  is the respective distance after feature projection
(or the distance between the corresponding predictions). Basically, if  is small,
 is also required to be small after projection. The goal of providing this
additional constraint or guidance as described in Eq. (3) is to better preserve the manifold of
relative distributions among different modalities. Although using the sparse regression
(based on L1 norm) can effectively select discriminative features from each modality
separately, it ignores the relationship among different modalities, which could make the
final selected features over-fitting to the data and thus affect the final performance.
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Therefore, the use of Eq. (3) is mainly for keeping the joint relationship among different
modalities, when each modality selects its own discriminative features. Note that, in this
way, the relationships among different modalities can be preserved via this constraint after
projection onto the low dimensional feature space.
By using the constraint given in Eq. (3), the objective function of the proposed multi-task
feature selection model can be further defined as
(4)
where λ1 > 0 and λ2 > 0 are the regularization parameters controlling, respectively, the
sparseness and the degree of preserving the inter-modality relationship. The optimization of
objective function in Eq. (4) can be solved using the Accelerated Proximal Gradient (APG)
method (Nesterov, 2003). In our application, the target vectors are the classification labels,
and we just have two modalities (MRI and PET) with the same target vector, i.e., m = 2 and
y1 = y2. The models constructed by different approaches are compared in Fig. 2.
Of note, all the procedures of feature selection are always performed on the training set,
without using the information from the test set. Also, each feature in the training set is
transformed into z score via the following transformation:
(5)
where  and σr are the mean and standard deviation of the r-th feature across all the
training subjects. The  and σr are also used to normalize the r-th feature fr in the test
subject.
It is also worth noting that, for feature selection, we just keep those features with non-zero
regression coefficients for the subsequent classification with SVM. For simplicity, in the
following, we still use  to denote a vector of the selected features for the j-th modality in
the i-th subject.
2.5. Multi-kernel SVM
Let  represents a feature vector of the i-th subject with m
modalities and yi ∈ {1, −1} denotes the corresponding class label. The primal optimization
problem of the traditional single-kernel SVM is given as:
(6)
where ξi denotes non-negative slack variable which measures the degree of misclassification
of the data, C denotes the penalty parameter which controls the amount of constraint
violations introduced by ξi, b denotes the bias term, q denotes the normal vector of
hyperplane, and Ø denotes the kernel-induced mapping function.
The dual form of single kernel SVM can be represented as below:
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where α is the Lagrange multiplier and k(xi, xp) = Ø(xi)TØ(xp) is the kernel function for
training samples xi and xp.
Given a new test sample v = {v1, …, vj, …, vm}, the decision function of single-kernel SVM
for predicted label is
(8)
Previous study demonstrated that multi-kernel SVM can effectively integrate the features
from different modalities compared to single-kernel SVM (Dai et al., 2012a; Zhang et al.,
2011). The primal optimization problem of a multi-kernel SVM is given as:
(9)
where βj ≥ 0 denotes the weighting factor on the j-th modality and with the constraint of
. Similarly as in the single-kernel SVM, the dual form of multi-kernel SVM is
given as:
(10)
where  denotes the kernel matrix for training samples  and 
for the j-th modality.
Given a new test sample v = {v1, …, vj, …, vm}, the decision function of multi-kernel SVM
for predicted label is
(11)
The multi-kernel SVM can be embedded into the single-kernel SVM by interpreting
 as a mixed kernel between the multi-modality training
samples xi and xp, and  as a mixed kernel between the multi-
modality training sample xi and the test sample v.
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SVM classifier was implemented by using the LIBSVM toolbox (Chang and Lin, 2011). A
ten-fold cross-validation strategy was used to evaluate the classification performance.
Specifically, the whole samples were randomly partitioned into ten subsets and then nine
subsets were chose for training and the remaining one was used for testing, and this
procedure was repeated ten times to avoid any bias introduced by randomly partitioning in
the cross-validation. To determine the optimal values for the parameters, i.e., the
regularization parameters λ1, λ2 and the above-mentioned kernel combination weight, we
performed another ten-fold cross-validation on the training samples. SVM model with the
best performance in this nested cross-validation was then used to classify the unseen test
samples. ACCuracy (ACC), SENsitivity (SEN) and SPEcificity (SPE) were calculated to
quantify the performance of all compared methods, which were defined respectively as
(12)
where TP is the number of true positives (number of patients correctly classified), TN is the
number of true negatives (number of NC correctly classified), FP is the number of false
positives (number of NC classified as patients), and FN is the number of false negatives
(number of patients classified as NC).
3. Experiment and Results
3.1. Experiment settings
The proposed approach was compared with three different classification approaches, i.e.,
Single modality approach using Single-Task feature selection (i.e., LASSO) and
conventional Single-kernel SVM (SSTS), Multi-modality approach using Single-Task
feature selection (i.e., LASSO) on each modality and Multi-kernel SVM (MSTM), and
Multi-modality approach using Joint feature Selection (i.e., L2,1 norm) and Multi-kernel
SVM (MJSM). It is worth noting that the same training and test data were used in all
methods for fair comparison. Performance of each comparison method was evaluated
through two different classification tasks: AD vs. NC and MCI vs. NC. The MCI dataset
used was the combination of all MCI converters and MCI non-converters.
3.2. Comparison of Results
As can be seen from Table 2, our proposed method consistently obtains better performance
than any of other three methods in AD/MCI classification. Fig. 3 further plots the Receiver
Operating Characteristic (ROC) curves of different methods for AD classification and MCI
classification, respectively. Specifically, for classifying AD from NC, the proposed method
achieves a classification accuracy of 94.37%, sensitivity of 94.71%, specificity of 94.04%,
and the Area Under the ROC Curve (AUC) of 0.9724, indicating excellent diagnostic power.
In contrast, the best performance is only 88.25% by using individual modality (i.e., SSTS,
when using PET), 91.02% by MSTM, and 91.10% by MJSM. On the other hand, for
classifying MCI from NC, the proposed method achieved a classification accuracy of
78.80%, sensitivity of 84.85%, specificity of 67.06%, and the AUC of 0.8284, while the best
performance is only 71.41% using the individual modality (i.e. SSTS, when using PET),
72.08% by MSTM, and 73.54% by MJSM. We also performed paired t-tests on the
classification accuracy between the proposed method and the other three comparison
methods, and the p values were provided in Table 2.
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3.3. Comparison with other existing methods
Furthermore, we compare the classification results of the proposed method with some results
reported in the literature, also mainly based on both PET and MRI data of the ADNI
subjects. Specifically, we compare with three recent studies as briefly described next.
Hinrichs and colleagues (2011) used 48 AD patients and 66 NC for AD diagnosis, and
obtained an accuracy of 87.60% by using imaging modalities (PET+MRI) and an accuracy
of 92.40% by using five modalities (MRI+PET+CSF+APOE+cognitive scores). No MCI vs.
NC classification result was reported in this paper. In Gray et al. (2013), they used 37 AD
patients, 75 MCI patients, and 35 NC for AD and MCI classifications. By using four
modalities (CSF+MRI+PET+Genetic) as features, they reported an accuracy of 89.00% for
AD classification and an accuracy of 74.60% for MCI classification. One of our previous
studies (Zhang et al., 2011), which used the same dataset as the present study, reported an
accuracy of 90.60% for AD classification by using MRI and PET and an accuracy of
93.20% for AD classification by using MRI, PET and CSF. Besides, they reported an
accuracy of 76.40% for MCI classification by using three modalities, and obtained an
accuracy of 73.79% if using only PET and MRI (which was obtained when we ran their
algorithm). The results of these methods, along with our proposed method, as reported in
Table 3, further validate the efficacy of our proposed method in both AD and MCI
classifications.
3.4. Effective of feature selection procedure
We also compare the performances of the aforementioned classification tasks using our
proposed feature selection method, or without using any feature selection (i.e., using all
features) since the number of original features (186) is comparable to the number of subject
samples. The same multi-kernel SVM framework is applied for both comparison methods.
As can be seen in Table 4, the proposed feature selection method performs much better than
the case without feature selection.
3.5. Classification between MCI converters and MCI non-converters (to AD)
Due to the heterogeneity of MCI patients, it is important to predict whether a certain MCI
patient will progress to AD within a certain period of time. Thus, a good AD/MCI
classification framework should be able to differentiate between different MCI subgroups,
i.e. MCI converters and MCI non-converters to AD. Based on Table 5 and Fig. 4, the
proposed method outperforms the comparison methods in the MCI subgroup classification.
Specifically, our method achieves accuracy of 67.83%, sensitivity of 64.88%, specificity of
70.00%, and the AUC of 0.6957, while the best performance is only 57.90% using
individual modality (i.e. SSTS, when using MRI), 61.71% by MSTM, and 65.74% by
MJSM, respectively. The results of MCI subgroup classification without feature selection
step are also provided in Table 4.
3.6. The most discriminative regions
In this subsection, we investigate the most discriminative regions that were selected by the
proposed feature selection method, i.e., for MCI subgroup classification. Since the feature
selection in each fold is performed only based on the training set, the selected features could
differ slightly across different cross-validation folds. We thus define the most discriminative
regions as regions that were most frequently selected in all cross-validations. The top ten
selected regions in PET and MRI were provided in Figs. 5–6, respectively. Most of selected
regions, e.g., hippocampal formation, precuneus and entorhinal cortex, are highly related to
AD pathology. In particular, hippocampal formation is a memory-related brain structure that
was always affected in the AD.
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3.7. Evaluation using a longitudinal dataset
We use the same longitudinal dataset as used in our previous study (Zhang and Shen, 2012)
to further evaluate the performance of our proposed method. The same procedure, including
feature selection, parameter determination, and cross-validation, is used for comparing the
performances of four methods in differentiating MCI converters from MCI non-converters.
The classification accuracies of the four methods are shown in Fig. 7, with the x-axis
indicating the scan time for the MCI subjects. It can be observed that the proposed method
consistently performs better than other 3 methods, and also the performances of all methods
increase for the late scanned images, since the separation between MCI converters and MCI
non-converters becomes larger and larger when subjects become older and older.
4. Discussion
This paper has presented a novel multi-modality multi-task feature selection approach for
brain disease diagnosis. Different from the conventional single-task feature selection, which
selects features independently from each modality, and also the joint feature selection using
the L2,1 norm, the proposed method considers the relationship of features from each
modality and then preserves the inter-modality relationship during the feature selection.
Experimental results show that our method can improve the performance of AD/MCI
diagnosis.
Several recent studies used multimodal imaging features for diagnosis of AD, and
demonstrated that the complementary information from different modalities could
significantly improve the classification results (Dai et al., 2012b; Fan et al., 2007; Walhovd
et al., 2010). However, feature selection in these studies was performed independently in
each modality. Thus, it may overlook the complementary information conveyed in different
modalities. Multi-task learning approach is a paradigm that learns a number of supervised
learning tasks simultaneously by exploiting the commonalities between them. Because it
allows the learner to use the relationship among different tasks, this often leads to a better
model than the case of learning these tasks independently (Evgeniou and Pontil, 2007). The
key of multi-task learning is to capture the intrinsic relationship among different tasks.
Actually, tasks can be related in various ways. The relationship of tasks was modeled by
different assumptions, e.g., (1) all tasks are close to each other in some norm (Bakker and
Heskes, 2003), (2) all tasks share a common underlying characteristic (Ben-David and
Schuller, 2003), or (3) all task have a common set of features (Argyriou et al., 2008).
We propose to preserve the relative distance between feature vectors of different modalities
of the same subject, before and after their projection to the low-dimensional feature space.
Promising classification performance we obtained also indicates a good diagnostic power
and generalizability of our proposed framework. As we can see from Table 2, the SSTS
method does not use the complementary information from other modalities and thus leads to
the lowest classification accuracy when using only single-modality features for
classification. Our finding, along with other multi-modality classification studies (Dai et al.,
2012b; Fan et al., 2007; Walhovd et al., 2010), demonstrates that the complementary
information in different modalities can help diagnose AD and MCI. On the other hand, both
MSTM and MJSM methods have better classification results than SSTS, but still lower than
our results. MSTM method performs feature selection in each modality independently
without considering the complementary information between modalities. On the other hand,
MJSM method forces too strongly for joint feature selection from different modalities, i.e.,
selecting same regional features from different modalities. Actually, the abnormal regions in
PET and MRI data could be different, e.g., some regions could have decreased GM volume
while still the normal metabolism, and other regions could have metabolic abnormality
while the normal GM volume (Ishii et al., 2005). Therefore, the complementary information
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conveyed by different modalities might be eliminated after this too-strong joint feature
selection, thus finally affecting the classification performance.
Furthermore, as shown in Table 3, our method is better than three other recent studies, even
though they used more modalities, which further shows the efficacy of our proposed method
in both AD and MCI classifications. Although direct comparison with the aforementioned
studies is not appropriate due to the possible use of different subjects (although from the
same ADNI dataset), the obtained results validate the promising performance of our method
for classification to some extent. For fair comparison, we also compared the results with our
previous study which used the same dataset. Better performance (compared to our previous
work) further validates the efficacy of our proposed method.
Classifying MCI converters from MCI non-converters has recently received a significant
amount of attention due to its importance for early AD diagnosis. In MCI patients, there are
typically two types of clinical changes: 1) MCI patients who will convert to AD in the future
time point, i.e., MCI-converters, and 2) MCI patients who will not convert after a certain
period of time, i.e., MCI non-converters. Early diagnosis of MCI conversion is of
tremendously important for possible delay of the disease, and prediction of progression of
the disease. For classifying MCI converters from MCI non-converters, as shown in Table 5,
our method achieves an accuracy of 67.83%, sensitivity of 64.88%, and specificity of
70.00%. Our accuracy and AUC are both higher than the comparison methods. Besides,
better classification results on a longitudinal dataset further demonstrate the robustness and
superiority of our proposed method.
Identification of objective biomarkers is of great interest as it could, ultimately, inform
clinical decisions of individual patients. With this consideration, our proposed feature
selection method seeks to identify those features that are the most discriminative in
classifying the MCI converters from MCI non-converters. These features include the
hippocampal formation, frontal, parietal, and occipital region. Specifically, hippocampal
formation plays an important role in the consolidation of information from short-term
memory to long-term memory (Eichenbaum et al., 1994; Jaffard and Meunier, 1993). This
region is one of the first brain regions to suffer damage, with memory loss and
disorientation, which are included among the early AD symptoms (Van Hoesen and Hyman,
1990). In addition, voxel-based analysis studies demonstrate significant changes in
perirhinal cortex (Leube et al., 2008), middle temporal gyrus (Busatto et al., 2003),
amygdala (Matsuda, 2013), entorhinal cortex (Derflinger et al., 2011), uncus (Yang et al.,
2012), and inferior frontal gyrus (Kim et al., 2011). Besides, PET studies showed significant
abnormalities in the precuneus (Del Sole et al., 2008), middle occipital gyrus (Smith et al.,
2009), superior parietal lobule (Potkin et al., 2002), inferior occipital gyrus (Melrose et al.,
2009), lingual gyrus (Eustache et al., 2004), superior frontal gyrus (Desgranges et al., 2002),
medial occipitotemporal gyrus (Matsuda, 2001), and angular gyrus (Hunt et al., 2006). The
fact that our results are consistent with the previous findings suggests the effectiveness of
our method in identifying biomarkers for MCI subgroup classification.
Although our proposed method demonstrates a good performance from cross-validations,
several limitations should be considered in the present study. First, the proposed feature
selection method requires the same number of features computed from different modalities.
Indeed, in addition to MRI and PET data, there are other modalities in ADNI database, such
as CSF and genetic data, which have different number of features. These modalities carry
important pathological information that can help further improve classification performance.
In the future work, we plan to extend our proposed method for including more modalities.
Second, we use 10-fold cross-validation strategy on ADNI dataset to evaluate performance
of our proposed method. Although we do not use separate dataset to test our method, 10-fold
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cross validation, as used popularly in the machine learning field for classification
performance evaluation, somehow tests the performance of our method on separate datasets.
Third, there is no consensus of a time boundary for MCI converters and non-converters.
Here, we use 18 months for an exploratory analysis. Further classification analysis should be
performed by using different time boundary in MCI subgroup classification. Finally,
although we use a cross-validation to evaluate the generalizability of our method, it is
important to test on a completely independent dataset in the future.
5. Conclusion
We have proposed a novel multi-task learning based feature selection method to effectively
preserve the complementary information from multi-modal neuroimaging data for AD/MCI
identification. Specifically, we treat the selection of features from each modality as a task
and then propose a new constraint to preserve the inter-modality relationship during the
feature selection. Experimental results on ADNI database demonstrate that our multi-task
feature selection method, after integrated with multi-kernel SVM, outperforms the state-of-
the-art methods. In the future, we will extend our work to include more modalities (such as
CSF and genetic features) for further improving AD/MCI classification performance.
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1. A novel multi-task feature selection method is proposed for AD/MCI diagnosis.
2. Proposed feature selection preserves potential strong inter-modality relationship.
3. Integration of multimodality data using multi-kernel SVM.
4. High accuracy of 94.37% for AD classification and 78.80% for MCI
classification.
5. Perform significantly better in distinguishing MCI-converters from non-
converters.
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Schematic diagram illustrating the proposed classification framework.
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Comparison of different feature selection models. Fig. 2A shows the model constructed by
the L1 norm, where feature selection is performed independently on each individual
modality. Fig. 2B shows the model constructed by the L2,1 norm, where a common set of
features is selected from all modalities. Fig. 2C shows the proposed feature selection model,
where, in additon to the common features selected across all modalities, the complementary
information conveyed by the modality-specific features is also effectively preserved.
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ROC curves of different methods for classification of AD (left) and MCI (right).
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ROC curves of different methods for classification of MCI subgroups.
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Top ten most discriminative PET regions in the MCI subgroup classification. Of note,
different colors in the figure just indicate different brain regions.
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Top ten most discriminative MRI regions in the MCI subgroup classification. Of note,
different colors in the figure just indicate different brain regions.
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Performances of four different methods on a longitudinal dataset. Our proposed method
achieves the best results, and the performances of all four methods are improved for the later
scans since the difference between MCI converters and MCI non-converters becomes larger
and larger with aging.
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Table 1
Characteristics of the subjects used in this study.
Characteristics AD (n = 51) MCI (n = 99) NC (n = 52)
Gender (M/F) 33/18 67/32 34/18
Age (mean ± SD) 75.2 ± 7.4 75.3 ± 7.0 75.3 ± 5.2
Education (mean ± SD) 14.7 ± 3.6 15.9 ± 2.9 15.8 ± 3.2
MMSE (mean ± SD) 23.8 ± 2.0 27.1 ± 1.7 29.0 ± 1.2
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Table 3
Comparison with the classification accuracies reported in the literature.
Method Subjects Modalities AD vs. NC (%) MCI vs. NC (%)
Zhang et al. (2011) 51AD+99MCI+52HC PET+MRI 90.60 -
Zhang et al. (2011) 51AD+99MCI+52HC PET+MRI+CSF 93.20 76.40
Hinrichs et al. (2011) 48AD+66NC PET+MRI 87.60 -
Hinrichs et al. (2011) 48AD+66NC MRI+PET+CSF+APOE+cognitive scores 92.40 -
Gray et al. (2013) 37AD+75MCI+35NC PET+MRI+CSF+Genetic 89.00 74.60
Proposed 51AD+99MCI+52NC PET+MRI 94.37 78.80
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